Engineered outer membrane vesicles enhance solid tumour CAR-T cell therapy
Harbin Medical University · Third Affiliated Hospital of Harbin Medical University · +4 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
9
total citations
- FWCI
- 109.16
- Percentile
- 100%
- References
- 47
Too recent for citation history.
Authors
15- XLXianjun LiCorresponding
Harbin Medical University, Third Affiliated Hospital of Harbin Medical University
- XLXuehan Li
Harbin Medical University, Third Affiliated Hospital of Harbin Medical University
- JSJiaqi Shi
Harbin Medical University, Third Affiliated Hospital of Harbin Medical University
- YLYingjing Li
Harbin Medical University, Third Affiliated Hospital of Harbin Medical University
- HZHanyu Zhang
Harbin Medical University, Second Affiliated Hospital of Harbin Medical University
Topics & keywords
Topics
Keywords
- Antigen
- Chimeric antigen receptor
- In vivo
- Immune system
- Lysis
- Cell therapy
- Immunosuppression
- Immunotherapy
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- HMHarbin Medical UniversityAward: HMUMIF-21004
- BXBeijing Xisike Clinical Oncology Research Foundation
- NNNational Natural Science Foundation of ChinaAwards: 2019-15, 82403891, U20A20377
- CPChina Postdoctoral Science FoundationAward: 2023MD744211
- CSChinese Society of Clinical OncologyAward: Y-tongshu2021/ms-0318
- NPNational Postdoctoral Program for Innovative TalentsAward: BX20240098